20 - Laserfiche WebLink

PUD Rezoning and Uses The applicant is proposing to rezone the subject site to PUD-C-O to allow for a mix of R&D, office, and laboratory land uses. The former retail center that occupied the subject site suffered from lack of investment and had difficulty maintaining tenant occupancy over the past decade. The proposed project provides an opportunity to redevelop the site with a high-quality office/commercial project consistent with other similar projects within the immediate vicinity of the Stoneridge Mall, such as Workday.l0x Genomics is already headquartered in Pleasanton and operates existing facilities with a similar profile of use at Stoneridge Corporate Plaza (6230 Stoneridge Mall Road), and at the Koll Center. The applicant seeks to build a master planned campus that would consolidate and allow for some expansion of their existing administrative operations and R&D activities onto one site. R&D and laboratory uses are included among a broad list of uses within the "light industrial" land use classification description in the PMC. The specific nature of the applicant's proposed uses includes highly specialized, technical activities including R&D, and small-scale assembly of instruments, consumables and software for analyzing biological systems. Per the applicant, these activities occur in clean-room environments that do not involve large- or industrial-scale processes or machinery; do not produce any noise or emissions and are relatively low in intensity from an employee density and trip generation standpoint. The City has permitted 10x Genomics' existing operations in locations that have similar zoning (PUD-C-O and PUD-I/C-O) to that proposed, and such uses have been found to be compatible with adjacent office, residential, and other uses, and have not caused negative impacts or issues. From an economic perspective,l0x Genomics is, today, among the City's largest sales tax generators. Staff was provided an opportunity to review information regarding current sales tax associated with 10x' Genomics existing facilities; the project would substantially expand 10x' business capacity, and with it, allow for a commensurate increase in sales tax. Furthermore, on a per square foot basis, 10x Genomics' existing sales tax generation is well above that of most typical retail sales tax generators in Pleasanton, by a significant margin.2 Considering the above, the Planning Commission supported staff's conclusion the proposed land uses are appropriate for the subject site and surrounding area, and the proposed PUD rezoning is appropriate. Sales tax data is considered confidential information, and thus current and projected data is not provided in this Agenda Report. 17